These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9765311)

  • 1. Protein kinase C-dependent in vivo phosphorylation of prourokinase leads to the formation of a receptor competitive antagonist.
    Franco P; Massa O; Garcia-Rocha M; Chiaradonna F; Iaccarino C; Correas I; Mendez E; Avila J; Blasi F; Stoppelli MP
    J Biol Chem; 1998 Oct; 273(42):27734-40. PubMed ID: 9765311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of human pro-urokinase on Ser138/303 impairs its receptor-dependent ability to promote myelomonocytic adherence and motility.
    Franco P; Iaccarino C; Chiaradonna F; Brandazza A; Iavarone C; Mastronicola MR; Nolli ML; Stoppelli MP
    J Cell Biol; 1997 May; 137(3):779-91. PubMed ID: 9151681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells.
    Busso N; Masur SK; Lazega D; Waxman S; Ossowski L
    J Cell Biol; 1994 Jul; 126(1):259-70. PubMed ID: 7517943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced activation of prourokinase by human RC2A leukemia cells.
    Tapiovaara H; Vaheri A; Alitalo R; Sim PS; Woodrow G; Stephens RW
    Semin Thromb Hemost; 1991 Jul; 17(3):251-61. PubMed ID: 1665587
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of receptor-dependent urokinase signaling by specific Ser to Glu substitutions.
    Carriero MV; Franco P; Gargiulo L; Vocca I; Cito L; Fontana L; Iaccarino C; Del Pozzo G; Guardiola J; Stoppelli MP
    Biol Chem; 2002 Jan; 383(1):107-13. PubMed ID: 11928806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urokinase receptor-dependent and -independent p56/59(hck) activation state is a molecular switch between myelomonocytic cell motility and adherence.
    Chiaradonna F; Fontana L; Iavarone C; Carriero MV; Scholz G; Barone MV; Stoppelli MP
    EMBO J; 1999 Jun; 18(11):3013-23. PubMed ID: 10357814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of second messengers following chemotactic and mitogenic urokinase-receptor interaction in human fibroblasts and mouse fibroblasts transfected with human urokinase receptor.
    Anichini E; Fibbi G; Pucci M; Caldini R; Chevanne M; Del Rosso M
    Exp Cell Res; 1994 Aug; 213(2):438-48. PubMed ID: 8050501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photoaffinity labeling of the human receptor for urokinase-type plasminogen activator using a decapeptide antagonist. Evidence for a composite ligand-binding site and a short interdomain separation.
    Ploug M; Ostergaard S; Hansen LB; Holm A; Danø K
    Biochemistry; 1998 Mar; 37(11):3612-22. PubMed ID: 9521680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.
    Vines DJ; Lee SW; Dichek DA; Ellis V
    J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reply to comment on 'Effect of purified, soluble urokinase receptor on the plasminogen-prourokinase activation system' (A. A-R. Higazi).
    Behrendt N; Danø K
    FEBS Lett; 1997 Feb; 402(2-3):293-4. PubMed ID: 9037213
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulation of the endothelial cell urokinase-type plasminogen activator receptor. Evidence for cyclic AMP-dependent and protein kinase C-dependent pathways.
    Langer DJ; Kuo A; Kariko K; Ahuja M; Klugherz BD; Ivanics KM; Hoxie JA; Williams WV; Liang BT; Cines DB
    Circ Res; 1993 Feb; 72(2):330-40. PubMed ID: 7678205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prourokinase activation on the surface of human rhabdomyosarcoma cells: localization and inactivation of newly formed urokinase-type plasminogen activator by recombinant class 2 plasminogen activator inhibitor.
    Pöllänen J; Vaheri A; Tapiovaara H; Riley E; Bertram K; Woodrow G; Stephens RW
    Proc Natl Acad Sci U S A; 1990 Mar; 87(6):2230-4. PubMed ID: 2138329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commentary on: 'Effect of purified soluble urokinase receptor on the plasminogen prourokinase activation system' by N. Behrendt and K. Dano, FEBS Letters, 393 (1996) 31-36.
    Higazi AA
    FEBS Lett; 1997 Feb; 402(2-3):291-2. PubMed ID: 9037212
    [No Abstract]   [Full Text] [Related]  

  • 14. Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness.
    Bryan L; Paugh BS; Kapitonov D; Wilczynska KM; Alvarez SM; Singh SK; Milstien S; Spiegel S; Kordula T
    Mol Cancer Res; 2008 Sep; 6(9):1469-77. PubMed ID: 18819934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the ligand binding activity of the human very low density lipoprotein receptor by protein kinase C-dependent phosphorylation.
    Sakthivel R; Zhang JC; Strickland DK; Gåfvels M; McCrae KR
    J Biol Chem; 2001 Jan; 276(1):555-62. PubMed ID: 11010963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44 stimulation by fragmented hyaluronic acid induces upregulation of urokinase-type plasminogen activator and its receptor and subsequently facilitates invasion of human chondrosarcoma cells.
    Kobayashi H; Suzuki M; Kanayama N; Nishida T; Takigawa M; Terao T
    Int J Cancer; 2002 Dec; 102(4):379-89. PubMed ID: 12402308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of human urokinase-type plasminogen activator to its receptor: residues involved in species specificity and binding.
    Quax PH; Grimbergen JM; Lansink M; Bakker AH; Blatter MC; Belin D; van Hinsbergh VW; Verheijen JH
    Arterioscler Thromb Vasc Biol; 1998 May; 18(5):693-701. PubMed ID: 9598826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacillolysin MA, a novel bacterial metalloproteinase that produces angiostatin-like fragments from plasminogen and activates protease zymogens in the coagulation and fibrinolysis systems.
    Narasaki R; Kuribayashi H; Shimizu K; Imamura D; Sato T; Hasumi K
    J Biol Chem; 2005 Apr; 280(14):14278-87. PubMed ID: 15677446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl10 is phosphorylated on Ser138 by Ca2+/calmodulin-dependent protein kinase II.
    Ishiguro K; Ando T; Goto H; Xavier R
    Mol Immunol; 2007 Mar; 44(8):2095-100. PubMed ID: 17052756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-talk between fMLP and vitronectin receptors triggered by urokinase receptor-derived SRSRY peptide.
    Gargiulo L; Longanesi-Cattani I; Bifulco K; Franco P; Raiola R; Campiglia P; Grieco P; Peluso G; Stoppelli MP; Carriero MV
    J Biol Chem; 2005 Jul; 280(26):25225-32. PubMed ID: 15866865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.